CROI | Penta

12

Mar, 2021

Sharing our understanding of the immune response of children living with HIV

EPIICAL is proud to have presented four abstracts at the CROI conference this year, sharing updated information on viral decay and the immune response of children living with HIV who begin treatment early in life. EFFECT OF HIV ON IMMUNE ACTIVATION AND EXHAUSTION IN CD4 AND CD8 T CELLS IN INFANTS Stefano Rinaldi, Vinh B. Dinh, Suresh Pallikkuth, Lesley D. Armas, Nadia Sitoe, Rajendra Pahwa, Nicola Cotugno, Paula Vaz, Paolo Palma, MariaGrazia Lain, Savita G. Pahwa DYNAMICS OF INTACT PROVIRAL SEQUENCES IN EARLY TREATED HIV-1 CLADE C–INFECTED INFANTS Catherine […]

11

Mar, 2021

ODYSSEY trial finds new drug is better for treating children living with HIV

Tags: HIV, ODYSSEY, CROI, Children

The anti-HIV drug Dolutegravir improves outcomes for children with HIV infection when given in a 3-drug combination. These results come from the ODYSSEY trial which was presented yesterday at the Conference on Retroviruses and Opportunistic Infections. Dolutegravir has a number of potential advantages, including: Few drug-to-drug interactions, making it easier to use when treating people who need treatment for other conditions such as tuberculosis High potency at a low milligram dose, meaning tablets can be small High genetic barrier to resistance Low cost Trials of dolutegravir in combination treatments in […]

6

Mar, 2020

Penta at CROI 2020

Tags: HIV, AIDS, CROI

The annual Conference on Retroviruses and Opportunistic Infections (CROI) will be held from March 8 to 11 in Boston, Massachusetts.

CROI brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases.

15

Mar, 2019

CROI 2019: Oral presentation by members of the EPIICAL team

Tags: EPIICAL, HIV, CROI

The annual Conference on Retroviruses and Opportunistic Infections (CROI) was held on 4-7 March 2019, at the Washington State Convention Center in Seattle, Washington. At this year’s event, EPIICAL team member Sara Dominguez Rodriguez delivered an engaging oral presentation on the earliest antiretroviral therapy initiation in infants.

1

Mar, 2019

CROI: Members of the EPIICAL team to attend in Seattle

Tags: EPIICAL, HIV, AIDS, CROI

Seattle is gearing up for the 2019 edition of CROI next week. Held at Washington State Convention Center on 4th-7th March, the Conference on Retroviruses and Opportunistic Infections is an important event in the Penta calendar, and in particular for the EPIICAL consortium, as it is an opportunity for members to discuss the latest developments pertaining to the project. Included on the agenda, EPIICAL project researchers will make an oral presentation illustrating recent results that provide further evidence that supports the earliest ART initiation in infants.

News

Sharing our understanding of the immune response of children living with HIV

ODYSSEY trial finds new drug is better for treating children living with HIV

Penta at CROI 2020

CROI 2019: Oral presentation by members of the EPIICAL team

CROI: Members of the EPIICAL team to attend in Seattle

A conceptual approach to the rationale for SARS-CoV-2 vaccine allocation prioritisation

Young infants exhibit robust functional antibody responses and restrained IFN-γ production to SARS-CoV-2

Because we all have to grow up”: supporting adolescents in Uganda to develop core competencies to transition towards managing their HIV more independently

DOLUTEGRAVIR-BASED ART IS SUPERIOR TO NNRTI/PI- BASED ART IN CHILDREN AND ADOLESCENTS